Biosensis offers alpha-synuclein antibodies to support advancement in neuroscience and neurodegenerative disease research. Designed for precise recognition of full-length human and rodent α-synuclein, the antibodies exhibit null cross-reactivity with beta or gamma synuclein and are able to identify endogenous α-synuclein in human plasma.
They show high affinity for human α-synuclein, including A30P or A53T Parkinson’s associated mutations, thus extending applicability in Parkinson’s disease studies. They are also said to enhance significance in the domain of Alzheimer’s disease research.
Phone: 02 9698 2022
Antibodies Inc recombinant antibodies
Recombinant chimeric antibodies are designed to offer several advantages beyond easy multiplexing.
Bioss Multiplex Fluorescent IHC Staining Kit
The Bioss Multiplex Fluorescent (5 Colors) IHC Staining Kit enables the simultaneous detection of...
AdipoGen immune checkpoint reagents for immuno-oncology research
AdipoGen Life Sciences offers a broad panel of immune checkpoint reagents, including recombinant...
